Several studies have demonstrated that increased expression of gelsolin is related to lower survival rates among patients with human prostate cancer, lung cancer, and oral cavity cancer.9, 10, 11, 15, 22 Moreover, a negative expression of gelsolin in patients with colon carcinoma closely associated with longer survival rates.13 This evidence concerns the gene GSN and Familial prostate cancer.